Mackenzie's Mission: The Australian Reproductive Carrier Screening Project

NCT04157595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18302

Last updated 2025-07-31

No results posted yet for this study

Summary

This study will investigate reproductive genetic carrier screening (RGCS) in 10,000 couples across Australia. Carrier screening for approximately 1300 genes associated with severe, childhood-onset, X-linked and autosomal recessive conditions will be performed on each member of the couple. A combined result will be issued indicating whether the couple has a 'low' or 'increased' risk of having a child with a genetic condition. It is anticipated that 1-2% of couples will be at an increased risk of having an affected child.

The study will evaluate all aspects of the RGCS program to assess the feasibility and acceptability of a publicly-funded population-wide RGCS program, including:

* education of recruiting healthcare providers
* education of participating couples
* implementation and uptake of RGCS
* frequency of increased-risk couples and their reproductive decisions
* psychosocial impacts
* ethical issues
* health economic implications
* health implementation research

Conditions

  • X-Linked Genetic Diseases
  • Autosomal Recessive Disorder

Interventions

OTHER

Reproductive Genetic Carrier Screening

Carrier screening for approximately 1300 genes associated with severe autosomal recessive and X-linked recessive conditions affecting children will be performed on each member of the couple. A combined result will be issued indicating whether the couple has a 'low' or 'increased' risk of having a child with a genetic condition

Sponsors & Collaborators

  • Australian Government Department of Health and Ageing

    collaborator OTHER_GOV
  • The University of New South Wales

    collaborator OTHER
  • The University of Western Australia

    collaborator OTHER
  • Harry Perkins Institute of Medical Research

    collaborator UNKNOWN
  • University of Sydney

    collaborator OTHER
  • Macquarie University, Australia

    collaborator OTHER
  • Griffith University

    collaborator OTHER
  • Victorian Clinical Genetics Services

    collaborator UNKNOWN
  • NSW Health Pathology

    collaborator UNKNOWN
  • PathWest Laboratory Medicine WA

    collaborator OTHER_GOV
  • King Edward Memorial Hospital

    collaborator OTHER
  • Royal Brisbane and Women's Hospital

    collaborator OTHER_GOV
  • Women's and Children's Hospital, Australia

    collaborator OTHER_GOV
  • Sydney Children's Hospitals Network

    collaborator OTHER
  • Royal Hobart Hospital

    collaborator OTHER_GOV
  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Martin Delatycki · Murdoch Children's Research Institute/Victorian Clinical Genetics Services

  • Edwin Kirk · Sydney Children's Hospital Network/NSW Health Pathology/UNSW

  • Nigel Laing · University of WA/Harry Perkins Institute/PathWest Laboratory Medicine

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2022-03-31
Completion
2024-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157595 on ClinicalTrials.gov